Omnicef
Omnicef

4.07
A generic medicine indicated for skin conditions and bacterial infections. Eases localized inflammation by disrupting the structural development of infectious bacteria.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Cefdinir
Reference Brand
Cefdinir
Product Origin
Generic Alternative
Reference Manufacturer
AbbVie
Product Form
Capsule
Regulatory Classification
Prescription Only Medicine
Primary Category
Antibiotics, Skin Care
Product Category
Third-Generation Cephalosporin
Pharmacological Class
Beta-Lactam Antibiotic
Manufacturer Description
Utilized to manage systemic bacterial infections to alleviate clinical pain and support cellular recovery.
Mechanism of Action
Blocks active peptidoglycan cross-linking inside growing bacterial cell walls, inducing osmotic lysis of pathogens.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
12–24 hours
Contraindications
Severe hypersensitivity to cephalosporins, History of severe penicillin anaphylaxis
Severe Adverse Events
Pseudomembranous colitis — requires immediate medical attention, Anaphylaxis — requires immediate medical attention
Common Side Effects
Diarrhea, Nausea, Headache
Uncommon Side Effects
Vaginal thrush, Abdominal pain, Skin rash
Drug Interactions
Iron Supplements, Antacids, Probenecid
Pregnancy Safety Warnings
TGA Category B: Generally safe. Breastfeeding: Clinically compatible.
Age Restrictions
Approved for infants over six months, children, and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Omnicef is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Blood Sugar Control - Diabex Australia